TRCT
BIOA

Tower Research Capital (TRC)’s BioAge Labs BIOA Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.2K Buy
2,872
+1,748
+156% +$33.7K ﹤0.01% 2737
2025
Q4 		$14.9K Sell
1,124
-1,471
-57% -$13K ﹤0.01% 3326
2025
Q3 		$15.3K Sell
2,595
-710
-21% -$3.33K ﹤0.01% 3552
2025
Q2 		$13.7K Buy
3,305
+901
+37% +$3.63K ﹤0.01% 3857
2025
Q1 		$9.04K Sell
2,404
-1,274
-35% -$5.89K ﹤0.01% 3831
2024
Q4 		$21.3K Buy
3,678
+3,641
+9,841% +$62.8K ﹤0.01% 3138
2024
Q3 		$770 Buy
+37
New +$741 ﹤0.01% 5268

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Tower Research Capital (TRC)'s BIOA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its BioAge Labs (BIOA) stake by 156% in Q1 2026, buying an estimated $33.7K and bringing the position to 2,872 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Tower Research Capital (TRC) first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Tower Research Capital (TRC) held 2,872 shares of BioAge Labs worth $50.2K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,748 BioAge Labs shares in Q1 2026, an estimated $33.7K.
  • BioAge Labs made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2737 holding.
  • Tower Research Capital (TRC) first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.